Transient binding of an activator BH3 domain to the Bak BH3-binding groove initiates Bak oligomerization

Journal of Cell Biology

Volumn 194, Issue 1, 2011, Pages 39-48

  Dai, Haiming ^a   Smith, Alyson ^b   Meng, X Wei ^a   Schneider, Paula A ^a   Pang, Yuan Ping ^b   Kaufmann, Scott H ^a,b  

^a MAYO CLINIC   (United States)

^b MAYO GRADUATE SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BH3 PROTEIN; CYTOCHROME C; LIPOSOME; MUTANT PROTEIN; PROTEIN BAK;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; BINDING KINETICS; CELL DEATH; COMPLEX FORMATION; CONTROLLED STUDY; EMBRYO; IN VITRO STUDY; MEMBRANE PERMEABILITY; MITOCHONDRION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OLIGOMERIZATION; POINT MUTATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; SURFACE PLASMON RESONANCE;

BCL-2 HOMOLOGOUS ANTAGONIST-KILLER PROTEIN; HUMANS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PROTEIN BINDING; PROTEIN MULTIMERIZATION; PROTEIN STRUCTURE, TERTIARY; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 79960235245     PISSN: 00219525     EISSN: 15408140     Source Type: Journal    
DOI: 10.1083/jcb.201102027     Document Type: Article

References (47)

1. Antonsson, B., S. Montessuit, B. Sanchez, and J.C. Martinou. 2001. Bax is present as a high molecular weight oligomer/complex in the mitochondrial membrane of apoptotic cells. J. Biol. Chem. 276:11615-11623.
2. Berendsen, H.J.C., J.P.M. Postma, W.F. van Gunsteren, A. Di Nola, and J.R. Haak. 1984. Molecular dynamics with coupling to an external bath. J. Chem. Phys. 81:3684-3690.
3. Berggård, T., S. Linse, and P. James. 2007. Methods for the detection and analysis of protein-protein interactions. Proteomics. 7:2833-2842.
4. Case, D.A., T.E. Cheatham III, T. Darden, H. Gohlke, R. Luo, K.M. Merz Jr., A. Onufriev, C. Simmerling, B. Wang, and R.J. Woods. 2005. The Amber biomolecular simulation programs. J. Comput. Chem. 26:1668-1688.
5. Chipuk, J.E., T. Moldoveanu, F. Llambi, M.J. Parsons, and D.R. Green. 2010. The BCL-2 family reunion. Mol. Cell. 37:299-310.
6. Cory, S., and J.M. Adams. 2002. The Bcl2 family: regulators of the cellular life-or-death switch. Nat. Rev. Cancer. 2:647-656.
7. Darden, T.A., D.M. York, and L.G. Pedersen. 1993. Particle Mesh Ewald: An N log(N) method for Ewald sums in large systems. J. Chem. Phys. 98:10089-10092.
8. Dewson, G., and R.M. Kluck. 2009. Mechanisms by which Bak and Bax permeabilise mitochondria during apoptosis. J. Cell Sci. 122:2801-2808.
9. Dewson, G., T. Kratina, H.W. Sim, H. Puthalakath, J.M. Adams, P.M. Colman, and R.M. Kluck. 2008. To trigger apoptosis, Bak exposes its BH3 domain and homodimerizes via BH3:groove interactions. Mol. Cell. 30:369-380.
10. Dewson, G., T. Kratina, P. Czabotar, C.L. Day, J.M. Adams, and R.M. Kluck. 2009. Bak activation for apoptosis involves oligomerization of dimers via their alpha6 helices. Mol. Cell. 36:696-703.
11. Du, H., J. Wolf, B. Schafer, T. Moldoveanu, J.E. Chipuk, and T. Kuwana. 2011. BH3 domains other than Bim and Bid can directly activate Bax/Bak. J. Biol. Chem. 286:491-501.
12. Ekström, F., A. Hörnberg, E. Artursson, L.G. Hammarström, G. Schneider, and Y.P. Pang. 2009. Structure of HI-6*sarin-acetylcholinesterase determined by X-ray crystallography and molecular dynamics simulation: reactivator mechanism and design. PLoS ONE. 4:e5957.
13. Gavathiotis, E., M. Suzuki, M.L. Davis, K. Pitter, G.H. Bird, S.G. Katz, H.C. Tu, H. Kim, E.H. Cheng, N. Tjandra, and L.D. Walensky. 2008. BAX activation is initiated at a novel interaction site. Nature. 455:1076-1081.
14. Goping, I.S., A. Gross, J.N. Lavoie, M. Nguyen, R. Jemmerson, K. Roth, S.J. Korsmeyer, and G.C. Shore. 1998. Regulated targeting of BAX to mitochondria. J. Cell Biol. 143:207-215.
15. Griffiths, G.J., B.M. Corfe, P. Savory, S. Leech, M.D. Esposti, J.A. Hickman, and C. Dive. 2001. Cellular damage signals promote sequential changes at the N-terminus and BH-1 domain of the pro-apoptotic protein Bak. Oncogene. 20:7668-7676.
16. Hackbarth, J.S., S.-H. Lee, X.W. Meng, B.T. Vroman, S.H. Kaufmann, and L.M. Karnitz. 2004. S-peptide epitope tagging for protein purification, expression monitoring, and localization in mammalian cells. Biotechniques. 37:835-839.
17. Hijikata, M., N. Kato, T. Sato, Y. Kagami, and K. Shimotohno. 1990. Molecular cloning and characterization of a cDNA for a novel phorbol-12-myristate-13-acetate-responsive gene that is highly expressed in an adult T-cell leukemia cell line. J. Virol. 64:4632-4639.
18. Hornak, V., R. Abel, A. Okur, B. Strockbine, A. Roitberg, and C. Simmerling. 2006. Comparison of multiple Amber force fields and development of improved protein backbone parameters. Proteins. 65:712-725.
19. Jason-Moller, L., M. Murphy, and J. Bruno. 2006. Overview of Biacore systems and their applications. Curr. Protoc. Protein Sci. Chapter 19: Unit 19.13.
20. Jiang, X., and X. Wang. 2004. Cytochrome C-mediated apoptosis. Annu. Rev. Biochem. 73:87-106.
21. Jorgensen, W.L., J. Chandreskhar, J.D. Madura, R.W. Impey, and M.L. Klein. 1983. Comparison of simple potential functions for simulating liquid water. J. Chem. Phys. 79:926-935.
22. Kiefer, F., K. Arnold, M. Künzli, L. Bordoli, and T. Schwede. 2009. The SWISSMODEL Repository and associated resources. Nucleic Acids Res. 37(Suppl. 1): D387-D392.
23. Kim, H., M. Rafiuddin-Shah, H.C. Tu, J.R. Jeffers, G.P. Zambetti, J.J. Hsieh, and E.H. Cheng. 2006. Hierarchical regulation of mitochondrion-dependent apoptosis by BCL-2 subfamilies. Nat. Cell Biol. 8:1348-1358.
24. Kim, H., H.C. Tu, D. Ren, O. Takeuchi, J.R. Jeffers, G.P. Zambetti, J.J. Hsieh, and E.H. Cheng. 2009. Stepwise activation of BAX and BAK by tBID, BIM, and PUMA initiates mitochondrial apoptosis. Mol. Cell. 36:487-499.
25. Kroemer, G., L. Galluzzi, and C. Brenner. 2007. Mitochondrial membrane permeabilization in cell death. Physiol. Rev. 87:99-163.
26. Kuwana, T., L. Bouchier-Hayes, J.E. Chipuk, C. Bonzon, B.A. Sullivan, D.R. Green, and D.D. Newmeyer. 2005. BH3 domains of BH3-only proteins differentially regulate Bax-mediated mitochondrial membrane permeabilization both directly and indirectly. Mol. Cell. 17:525-535.
27. Letai, A., M.C. Bassik, L.D. Walensky, M.D. Sorcinelli, S. Weiler, and S.J. Korsmeyer. 2002. Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics. Cancer Cell. 2:183-192.
28. Lovell, J.F., L.P. Billen, S. Bindner, A. Shamas-Din, C. Fradin, B. Leber, and D.W. Andrews. 2008. Membrane binding by tBid initiates an ordered series of events culminating in membrane permeabilization by Bax. Cell. 135:1074-1084.
29. Meng, X.W., S.H. Lee, H. Dai, D. Loegering, C. Yu, K. Flatten, P. Schneider, N.T. Dai, S.K. Kumar, B.D. Smith, et al. 2007. Mcl-1 as a buffer for proapoptotic Bcl-2 family members during TRAIL-induced apoptosis: a mechanistic basis for sorafenib (Bay 43-9006)-induced TRAIL sensitization. J. Biol. Chem. 282:29831-29846.
30. Moldoveanu, T., Q. Liu, A. Tocilj, M. Watson, G. Shore, and K. Gehring. 2006. The X-ray structure of a BAK homodimer reveals an inhibitory zinc binding site. Mol. Cell. 24:677-688.
31. Montessuit, S., S.P. Somasekharan, O. Terrones, S. Lucken-Ardjomande, S. Herzig, R. Schwarzenbacher, D.J. Manstein, E. Bossy-Wetzel, G. Basañez, P. Meda, and J.C. Martinou. 2010. Membrane remodeling induced by the dynamin-related protein Drp1 stimulates Bax oligomerization. Cell. 142:889-901.
32. Oda, E., R. Ohki, H. Murasawa, J. Nemoto, T. Shibue, T. Yamashita, T. Tokino, T. Taniguchi, and N. Tanaka. 2000. Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis. Science. 288:1053-1058.
33. Oh, K.J., P. Singh, K. Lee, K. Foss, S. Lee, M. Park, S. Lee, S. Aluvila, M. Park, P. Singh, et al. 2010. Conformational changes in BAK, a pore-forming proapoptotic Bcl-2 family member, upon membrane insertion and direct evidence for the existence of BH3-BH3 contact interface in BAK homo-oligomers. J. Biol. Chem. 285:28924-28937.
34. Pang, Y.-P. 2004. Three-dimensional model of a substrate-bound SARS chymotrypsin-like cysteine proteinase predicted by multiple moleculardynamics simulations: catalytic efficiency regulated by substrate binding. Proteins. 57:747-757.
35. Pearlman, D.A., D.A. Case, J.W. Caldwell, W.S. Ross, T.E. Cheatham III, S. DeBolt, D. Ferguson, G. Seibel, and P.A. Kollman. 1995. AMBER, a package of computer programs for applying molecular mechanics, normal-mode analysis, molecular-dynamics and free-energy calculations to simulate the structural and energetic properties of molecules. Comput. Phys. Commun. 91:1-41.
36. Pitter, K., F. Bernal, J. Labelle, and L.D. Walensky. 2008. Dissection of the BCL-2 family signaling network with stabilized alpha-helices of BCL-2 domains. Methods Enzymol. 446:387-408.
37. Reed, J.C. 2006. Proapoptotic multidomain Bcl-2/Bax-family proteins: mechanisms, physiological roles, and therapeutic opportunities. Cell Death Differ. 13:1378-1386.
38. Ren, D., H.C. Tu, H. Kim, G.X. Wang, G.R. Bean, O. Takeuchi, J.R. Jeffers, G.P. Zambetti, J.J. Hsieh, and E.H. Cheng. 2010. BID, BIM, and PUMA are essential for activation of the BAX- and BAK-dependent cell death program. Science. 330:1390-1393.
39. Sattler, M., H. Liang, D. Nettesheim, R.P. Meadows, J.E. Harlan, M. Eberstadt, H.S. Yoon, S.B. Shuker, B.S. Chang, A.J. Minn, et al. 1997. Structure of Bcl-xL-Bak peptide complex: recognition between regulators of apoptosis. Science. 275:983-986.
40. Shao, J., S.W. Tanner, N. Thompson, and T.E. Cheatham III. 2007. Clustering molecular dynamics trajectories: 1. Characterizing the performance of different clustering algorithms. J. Chem. Theory Comput. 3:2312-2334.
41. Smith, A.J., H. Dai, C. Correia, R. Takahashi, S.H. Lee, I. Schmitz, and S.H. Kaufmann. 2011. Noxa/Bcl-2 protein interactions contribute to bortezomib resistance in human lymphoid cells. J. Biol. Chem. 286:17682-17692.
42. Walensky, L.D., K. Pitter, J. Morash, K.J. Oh, S. Barbuto, J. Fisher, E. Smith, G.L. Verdine, and S.J. Korsmeyer. 2006. A stapled BID BH3 helix directly binds and activates BAX. Mol. Cell. 24:199-210.
43. Wei, M.C., T. Lindsten, V.K. Mootha, S. Weiler, A. Gross, M. Ashiya, C.B. Thompson, and S.J. Korsmeyer. 2000. tBID, a membrane-targeted death ligand, oligomerizes BAK to release cytochrome c. Genes Dev. 14:2060-2071.
44. Wei, M.C., W.X. Zong, E.H. Cheng, T. Lindsten, V. Panoutsakopoulou, A.J. Ross, K.A. Roth, G.R. MacGregor, C.B. Thompson, and S.J. Korsmeyer. 2001. Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science. 292:727-730.
45. Wickstrom, L., A. Okur, and C. Simmerling. 2009. Evaluating the performance of the ff99SB force field based on NMR scalar coupling data. Biophys. J. 97:853-856.
46. Willis, S.N., J.I. Fletcher, T. Kaufmann, M.F. van Delft, L. Chen, P.E. Czabotar, H. Ierino, E.F. Lee, W.D. Fairlie, P. Bouillet, et al. 2007. Apoptosis initiated when BH3 ligands engage multiple Bcl-2 homologs, not Bax or Bak. Science. 315:856-859.
47. Youle, R.J., and A. Strasser. 2008. The BCL-2 protein family: opposing activities that mediate cell death. Nat. Rev. Mol. Cell Biol. 9:47-59.